The 5th annual OCMF Conference will be held November 13 & 14, 2023


The 2023 Ovarian Cancer Midwest Focus (OCMF) Conference will be both an in-person and a virtual conference that will include live streamed discussion rounds with national and international speakers, short talks based on abstracts, and group discussions. Topics will include Early Detection, Immunotherapy, Novel Therapeutics, Metabolism, Preclinical Models of Ovarian Cancer, Personalized Medicine, Microenvironment, Epigenetics, PARP Inhibitors, Chemoresistance, Combination Therapy, Clinical Studies, Technology Commercialization, and Career Development (lunch and learn). 


The conference is single-track (no concurrent sessions) to give all attendees the opportunity to hear all presentations and discussions. Each day will feature Keynote Speakers, Flash Talks, and Lunch & Learn Presentations.

See here for more info


Oral presentations are 5 minutes in length and are given in a plenary format to an interdisciplinary audience of approximately 100 attendees. Hence, the content should be interesting to a diverse audience and clearly focused to deliver two or three key points.

This conference aims to provide a collaborative environment which will allow an interdisciplinary approach to ovarian cancer research; a broad range of topics will be covered that address topic areas related to ovarian cancer research, including:

- Chemoresistance -
- Clinical Studies -
- Combination Therapy -
- Early detection -
- Epigenetics -
- Immunotherapy -
- Metabolism -
- Microenvironment -
- Novel Therapeutics -
- PARP Inhibitors -
- Personalized medicine -
- Preclinical models of ovarian cancer -

More info on proposal submissions coming soon.